Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Ministry of Education, Science and Culture of the State of Mecklenburg-Vorpommern | UNKNOWN |
| Ministry of Social Affairs, Integration and Equality of the State of Mecklenburg-Vorpommern | UNKNOWN |
| State Office for Health and Social Affairs of the State of Mecklenburg-Vorpommern |
Not provided
Not provided
Not provided
Not provided
The main objectives of this study are
Detailed Description:
This study aims to collect information on teachers and childcare educators as well as on pupils and preschoolers in the State of Mecklenburg-Vorpommern
Over a 5 month period, 5 study visits per participant are planned. At each visit, nasal/throat swabs (for PCR testing) will be collected and participants will be asked to fill in a questionnaire (asking for SARS-CoV-2 risk factors, perceived risk, and impact of the pandemic on their quality of life). In adults, additional blood samples (for SARS-CoV-2 antibody testing) will be collected at the first and the last study visit. This will help to gain a better understanding of viral load and antibody development over time.
The remaining blood samples will be stored in a repository for future research.
The study is part of a modular SARS-CoV-2-research programme of the University Medicine Greifswald.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| teacher |
|
| |
| pupils |
|
| |
| childcare educators |
|
| |
| preschoolers |
|
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Nasopharyngeal swab | Diagnostic Test | SARS-CoV-2 PCR |
|
| Measure | Description | Time Frame |
|---|---|---|
| Share of participants with SARS-CoV-2 detectable in PCR | Percentage of SARS-CoV-2 PCR positive participants (children and educational staff) | 5 months |
| Measure | Description | Time Frame |
|---|---|---|
| Seroprevalence of SARS-CoV-2 antibodies | Percentage of Anti-SARS-COV2 S protein IgA and IgA ELISA positive participants (educational staff) | At study inclusion |
| Seroprevalence of SARS-CoV-2 antibodies |
Not provided
Inclusion criteria:
Exclusion criteria:
- None
Not provided
Not provided
Teachers and childcare educators as well as pupils and preschoolers
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nils-Olaf Hübner, Prof. Dr. | University Medicine Greifswald | Principal Investigator |
| Karsten Becker, Prof. Dr. | University Medicine Greifswald | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Greifswald University Medicine | Greifswald | Germany |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| UNKNOWN |
Not provided
Not provided
Not provided
serum, nasal/throat swabs
| Serum testing | Diagnostic Test | Anti-SARS-CoV-2 antibody testing (IgA and IgG ELISA) |
|
Percentage of Anti-SARS-COV2 S protein IgA and IgA ELISA positive participants (educational staff)
| 5 months |
| SARS-CoV-2 risk factors, perceived risk of infection, and impact of the pandemic on quality of life | As assessed by a monthly questionnaire | At study inclusion |
| SARS-CoV-2 risk factors, perceived risk of infection, and impact of the pandemic on quality of life | As assessed by a monthly questionnaire | 1 month |
| SARS-CoV-2 risk factors, perceived risk of infection, and impact of the pandemic on quality of life | As assessed by a monthly questionnaire | 2 months |
| SARS-CoV-2 risk factors, perceived risk of infection, and impact of the pandemic on quality of life | As assessed by a monthly questionnaire | 3 months |
| SARS-CoV-2 risk factors, perceived risk of infection, and impact of the pandemic on quality of life | As assessed by a monthly questionnaire | 4 months |
| SARS-CoV-2 risk factors, perceived risk of infection, and impact of the pandemic on quality of life | As assessed by a monthly questionnaire | 5 months |
| Share of participants with SARS-CoV-2 detectable in PCR | Percentage of SARS-CoV-2 PCR positive participants (children and educational staff) | At study inclusion |
| Share of participants with SARS-CoV-2 detectable in PCR | Percentage of SARS-CoV-2 PCR positive participants (children and educational staff) | 1 month |
| Share of participants with SARS-CoV-2 detectable in PCR | Percentage of SARS-CoV-2 PCR positive participants (children and educational staff) | 2 months |
| Share of participants with SARS-CoV-2 detectable in PCR | Percentage of SARS-CoV-2 PCR positive participants (children and educational staff) | 3 months |
| Share of participants with SARS-CoV-2 detectable in PCR | Percentage of SARS-CoV-2 PCR positive participants (children and educational staff) | 4 months |